The CNS Board members include:

Luci Barbie, Pharm D, CRC, CRA

Background:

Luci Barbie career in clinical research began in 1997 when she came to the United States for a fellowship at The Medical Research Center in Washington, D.C.  conducting phase II – IV clinical and device studies in nephrology, hypertension, and hyperlipidemia.

In 1999 Luci was certified as Clinical Research Coordinator by the Association of Clinical Research Professionals.

In January of 2000 Luci joined the research department of the Center for Neurologic Study as the Lead Clinical Research Coordinator of its sister organization CCR, conducting clinical trials in ALS, Alzheimer’s disease, Parkinson’s disease, MS, diabetic neuropathy, and chronic pain.  A year later she became the site manager of CCR in charge of study budget and contract negotiations with different Pharmaceutical sponsors.

Her experience includes research site management, regulatory submission, internal quality assurance, development of SOPs, training of newly hired clinical coordinators and sub-investigators, patient recruitment and retention, coordinating studies from start to finish, and serving as the liaison between the site and sponsors, CROs, and IRBs.  Luci has a thorough knowledge of clinical research methodology including FDA regulations, GCP and ICH guidelines. Leveraging this experience, she recently took a position as a Clinical Research Associate at a Clinical Research Organization in Orange County. 

Working for so many years with ALS patients and their caregivers, Luci has a particular interest in ALS research.   She believes in CNS’s mission of developing treatments and perhaps finding the cure for this and others incurable neurological diseases.

Significant Contributions and Achievements:

As a Pharmacist is Peru, Luci worked in the Peruvian Amazonia of Loreto as a member of a health professional team (MD, Pharmacist, RNs, DDS) created by the Peruvian government for towns secluded from medical care.   Luci’s main duty was to go out by canoe or small boats to towns located along the Amazon river to open small pharmacy stations and to train technicians to manage them.  She was responsible for the supervision and inventory of all drugs at each satellite pharmacy.  Therefore, her travels on the Amazon river were quite frequent.  As part of the special health team, she contributed educating the habitants of each town about health and the correct use of pharmacological drugs.

Education:

Luci received her Bachelor degree in Pharmacy and Biochemistry and her Professional Title degree as Pharm D from the University of Trujillo in Peru.

Steve Bordner

Background:

Steve Bordner is a Vice President at CBRE. He started his real estate career with Coldwell Banker Commercial Real Estate in 1980, specializing in transactions on the Eastside. In 1983, he ventured into real estate development with Evergreen Management Company. Steve returned to CBRE in October of 1998 to focus on the leasing and sale of industrial/high-technology and office properties. He is currently a member of Washington State Commercial Association of Realtors. Also, he is a licensed managing broker in the State of Washington.

As a member of a family impacted by ALS, Mr. Bordner is an advocate for the patients and families affected by neurological illness.

Significant Contributions and Achievements:

Prior to re-joining CBRE, Steve was involved in the development, construction, leasing, management and sale of more than 1 million square feet of commercial real estate. Also during that time he was involved in the platting of residential lots, plus the development and construction of single-family and duplex homes. After joining CBRE, Steve earned the CBRE Top 10 designation for Puget Sound region in 2008.

Education:

Steve has a Bachelor of Arts degree in Economics from the University of Washington. He earned his Master of Business Administration, also from the University of Washington.

Yardy Tse, MD

Background:

Dr. Yardy Tse is Board Certified by the American Board of Dermatology and received her medical degree at the University of Michigan. After completing an internship in internal medicine at the University of Pennsylvania, Dr. Tse received her dermatology specialty training from New York University where she was honored as Chief Resident. In pursuit of her interests in Dermatologic and Cosmetic Surgery, Dr. Tse completed specialized fellowship training in Laser and Cosmetic Surgery and Mohs surgery at New York University.

A Fellow of the American Academy of Cosmetic Surgery, Dr. Tse has a particular interest in the diagnosis and treatment of skin cancer and the use of laser cosmetic surgery for the treatment of a variety of skin conditions.

Dedicated to the future of dermatology, Dr. Tse is also an Assistant Clinical Professor in the Division of Dermatology at UCSD School of Medicine, where she volunteers and teaches dermatologic surgery to residents and medical students.

As a long standing board member, Dr. Tse is dedicated to CNS’s mission of the development of treatments for presently incurable neurological disorders.

Education:

Dr. Tse received her Bachelor of Arts degree in Biomedical Sciences Major from the University of Michigan, Ann Arbor. She earned her medical degree with a Distinction in Research Award also from University of Michigan, Ann Arbor.

Tania Schweig, M.Ed.

Background:

Tania began her career in special education in 1994 working with severely emotionally disturbed students in a non-public day treatment facility.  Following this, she spent two years teaching learning disabled students in the public schools as a Special Education Class teacher. 

Tania first joined Oakland Hebrew Day School (OHDS) in 2000 as the head of Special Education, helping to develop and grow the school’s Resource Program.   During her 11 years as OHDS’ Resource Specialist, she worked closely with students, teachers and parents to understand and develop plans to support student learning.  As a result of this experience, she developed an interest in language processing and memory, creating specialized curriculum to support students with processing deficits in these areas.

In 2011 Tania was appointed as the Director of General Studies at OHDS. In her current role Tania works closely with teachers to develop curriculum, oversees instructional practices with an eye on creating a 21st century learning environment, and continues to work closely with families and outside specialists to support the needs of students with serious learning disabilities, attention challenges and emotional needs. As an educator, Tania is interested in the advancements made in the field of neuroscience as a means of understanding learning disorders, an evolving field of study that CNS may be able to contribute to.

Significant Contributions and Achievements:

During her time in Oakland Hebrew Day School, Tania has created and implemented an interdisciplinary K-8 science program with focus on STEM learning. She has also piloted project-based learning approaches in K-8 education with specific emphasis on math and science enrichment and digital media production. Her current on-going efforts involve using hybrid learning methods for professional development of teachers, and integrating technology and social media in adult learning.

Education:

Tania has a Bachelor of Arts degree in Sociology from the University of California, Berkeley. She earned her Master of Education and credential in Special Education from the University of San Francisco. 

Richard A. Smith, M.D.

Background:

During his neurology residency at Stanford University, Dr. Smith began his first studies of Lou Gehrig's Disease which has remained his principal career interest. His initial studies focused on the symptomatic treatment of ALS but at Scripp's Research Institute, he began to research the cause of ALS and subsequently directed his major effort to developing a therapy for ALS and kindred disorders.

Significant Contributions and Achievements:

His earliest publications in the New England Journal, British Medical Journal, etc. were among the first publications to demonstrate the utility of symptomatic management in the care of ALS patients. Among the first investigator to recognize the potential of interferon as a treatment modality, Dr. Smith's work contributed to the adoption of interferon as one of the first treatments for multiple sclerosis. And, along with colleagues Barry Festoff and Schlomo Melmed, Dr. Smith conducted the first trial of a growth factor (IGF-1) as a treatment for a neurological disease. More recent achievements include the development of DMQ which was approved by FDA in 2011 for the treatment of emotional lability and the development of antisense therapeutics, along with colleagues at UCSD and Isis Pharmaceutical Corp, as potential  treatment for familial neurological disorders such as Huntington's Disease and familial ALS. On June 2014, the ALS Association awarded Dr. Smith an Essey prize for his efforts to develop a treatment for familial ALS.

Education:

Dr. Smith attended Brandeis University and subsequently, received his medical degree from the University of Miami. Following graduation from medical school, he interned at Jackson Memorial Hospital after which he obtained his neurology training at Stanford University.